Lamictal Case Won't Be Paused For Class Cert. Appeal
A New Jersey federal judge on Friday refused to pause a case accusing GlaxoSmithKline PLC and Teva Pharmaceutical Industries Ltd. of delaying the entry of generic alternatives to epilepsy drug Lamictal...To view the full article, register now.
Already a subscriber? Click here to view full article